While 2seventy bio Inc has underperformed by -0.56%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, TSVT fell by -41.91%, with highs and lows ranging from $12.69 to $1.53, whereas the simple moving average jumped by 3.43% in the last 200 days.
On January 31, 2024, Leerink Partners Upgraded 2seventy bio Inc (NASDAQ: TSVT) to Outperform. A report published by TD Cowen on January 31, 2024, Downgraded its rating to ‘Market Perform’ for TSVT. Leerink Partners also Downgraded TSVT shares as ‘Market Perform’, setting a target price of $6 on the company’s shares in a report dated October 30, 2023. Citigroup Initiated an Buy rating on October 12, 2023, and assigned a price target of $13. Goldman September 13, 2023d its ‘Buy’ rating to ‘Neutral’ for TSVT, as published in its report on September 13, 2023. Morgan Stanley also rated the stock as ‘Equal-Weight’.
Analysis of 2seventy bio Inc (TSVT)
Further, the quarter-over-quarter decrease in sales is -80.98%, showing a negative trend in the upcoming months.
2seventy bio Inc’s future performance can be determined with the help of several well-rounded types of analysis and research techniques, with equity being one of the most influential. The goal here is to ensure that your current return on equity of -76.91% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 3.98, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
The average volume for any stock is also a very valuable indicator of volatility, and TSVT has an average volume of 1.48M. On a monthly basis, the volatility of the stock is set at 12.12%, whereas on a weekly basis, it is put at 11.16%, with a gain of 7.21% over the past seven days. Furthermore, long-term investors anticipate a median target price of $11.20, showing growth from the present price of $5.35, which can serve as yet another indication of whether TSVT is worth investing in or should be passed over.
How Do You Analyze 2seventy bio Inc Shares?
In addition to analyzing the fundamentals, it is also important to look at how many company employees own stock. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 6.81%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 95.14% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
TSVT shares are owned by institutional investors to the tune of 95.14% at present.
